Sign in

CIK 0001133869

  • Non-accelerated filer
  • Smaller reporting company

CAPRICOR THERAPEUTICS, INC.

Sign in to watch
Ticker
CAPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 310-358-3200
Business address
10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
Former names
Nile Therapeutics, Inc., SMI PRODUCTS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-21 Manzo Louis Director Option exercise +1,401 $1.39 $2K 62,599
2023-02-21 Manzo Louis Director Returned to the company −452 $4.31 $2K 62,147
2023-02-21 Manzo Louis Director Option exercise · Stock Option (Right to Buy) −1,401 0
2023-01-03 Manzo Louis Director Grant or award · Stock Option (Right to Buy) +37,770 37,770
2023-01-03 Manzo Louis Director Grant or award · Stock Option (Right to Buy) +7,120 7,120
2023-01-03 Manzo Louis Director Grant or award · Stock Option (Right to Buy) +19,000 19,000
2022-03-31 Manzo Louis Director Option exercise +27,904 $1.39 $39K 27,904
2022-03-31 Manzo Louis Director Shares withheld for taxes −11,309 $3.43 $39K 16,595
2022-03-31 Manzo Louis Director Option exercise · Stock Option (Right to Buy) −15,455 0
2022-03-31 Manzo Louis Director Option exercise · Stock Option (Right to Buy) −12,449 0
2022-01-03 Manzo Louis Director Grant or award · Stock Option (Right to Buy) +83,590 83,590
2021-01-04 Manzo Louis Director Grant or award · Stock Option (Right to Buy) +72,066 72,066
2020-09-24 Manzo Louis Director Option exercise +8,299 $3.70 $31K 44,603
2020-09-24 Manzo Louis Director Option exercise · Stock Option (Right to Buy) −8,299 0
2020-06-05 Manzo Louis Director Grant or award · Stock Option (Right to Buy) +83,000 83,000
2020-02-12 Manzo Louis Director Grant or award · Stock Option (Right to Buy) +4,500 4,500
2020-02-12 Manzo Louis Director Grant or award · Stock Option (Right to Buy) +2,550 2,550
2020-02-12 Manzo Louis Director Grant or award · Stock Option (Right to Buy) +2,356 2,356
2020-02-12 Manzo Louis Director Grant or award · Stock Option (Right to Buy) +3,000 3,000
2020-02-12 Manzo Louis Director Grant or award · Stock Option (Right to Buy) +1,500 1,500

Page 1 of 3 · 42 trades